KOL: How Can Healthcare Professionals Improve Patient Outcomes in Those with Cirrhosis?
GHAPPcast4 Mars 2025

KOL: How Can Healthcare Professionals Improve Patient Outcomes in Those with Cirrhosis?

Cirrhosis is a progressive liver disease that requires early detection, effective management, and patient education to improve outcomes. In this video, Allison Moser, NP, a Transplant Hepatology Nurse Practitioner at Rush University Medical Center, shares key strategies for healthcare professionals to enhance patient care.

She discusses the importance of early screenings for high-risk individuals, including those with a history of alcohol use, metabolic syndrome, and viral hepatitis. By utilizing blood tests, imaging, and elastography, providers can detect cirrhosis early and intervene before complications arise. Managing the root cause—whether through antivirals, alcohol cessation, or lifestyle modifications—is critical to slowing disease progression.

As cirrhosis advances, patients may develop ascites, esophageal varices, and hepatic encephalopathy. Allison explains how medications like diuretics, beta-blockers, lactulose, and rifaximin help manage these complications and reduce hospitalizations. For patients with end-stage liver disease, early referral for liver transplant evaluation using MELD score assessments can be life-saving.


Beyond medical treatment, patient education and mental health support play a crucial role. Healthcare professionals must emphasize healthy lifestyle choices, alcohol avoidance, and emotional well-being to empower patients in managing their condition. A multidisciplinary approach, involving hepatologists, dietitians, and mental health specialists, ensures comprehensive patient care.


Stay informed on the latest research and treatment options to provide the best possible outcomes for cirrhosis patients. Subscribe for more expert insights and visit the Gastroenterology & Hepatology Advanced Practice Provider (GHAPP) website for additional resources. #Cirrhosis #LiverHealth #Hepatology #Transplant #Gastroenterology

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(164)

Linerixibat Medication Review

Linerixibat Medication Review

Christina Hanson, FNP, and Dr. Marcelo Kugelmas of South Denver Gastroenterology review linerixibat, an ileal bile acid transporter (IBAT) inhibitor, and its role in managing cholestatic pruritus in p...

22 Sep 13min

Podcast: Managing Fatigue and Pruritus in Your Patients With PBC

Podcast: Managing Fatigue and Pruritus in Your Patients With PBC

How can clinicians better recognize and manage itching and fatigue in primary biliary cholangitis (PBC)? In this podcast, hepatology clinicians from RUSH University Medical Center discuss the impact o...

15 Sep 15min

Podcast: How to Screen and Diagnose Cholestatic Liver Diseases

Podcast: How to Screen and Diagnose Cholestatic Liver Diseases

In this episode, HoChong Gilles of the Richmond VA Medical Center, and Alison Moe of Atlanta Gastroenterology discuss a practical, step-by-step approach to screening for and diagnosing cholestatic liv...

25 Aug 20min

GHAPPcast: Recognizing and Managing Overt Hepatic Encephalopathy

GHAPPcast: Recognizing and Managing Overt Hepatic Encephalopathy

Thank you to Salix for their support on this podcast episode. In this GHAPP podcast, host Christina Hanson, FNP, welcomes Janet Gripshover, DNP, FNP-BC, MBA, for a practical discussion on recognizing ...

18 Aug 48min

FAQ: Counseling Patients on Overt Hepatic Encephalopathy

FAQ: Counseling Patients on Overt Hepatic Encephalopathy

Thank you to Salix for their support on this FAQ video module.In this FAQ video module, Natalie Oliver, PA-C, discusses how healthcare professionals can counsel patients and caregivers about overt hep...

11 Aug 4min

FAQ: Identifying & Diagnosing Overt Hepatic Encephalopathy

FAQ: Identifying & Diagnosing Overt Hepatic Encephalopathy

Thank you to Salix for their support on this FAQ video module. In this FAQ video module, Samantha Ramirez, NP-C, discusses how healthcare professionals can identify and diagnose overt hepatic encephal...

4 Aug 2min

Subgroup Analysis: Differences in Maintenance Dosing For UC and CD

Subgroup Analysis: Differences in Maintenance Dosing For UC and CD

Thank you to Johnson & Johnson for their support on this podcast episode. In this GHAPP podcast, Amy Stewart, NP, of Capital Digestive Care, introduces a practical inflammatory bowel disease discussio...

23 Juli 7min

Medication Review: Efficacy & Safety of Risankizumab in Patients with Moderate to Severely Active UC

Medication Review: Efficacy & Safety of Risankizumab in Patients with Moderate to Severely Active UC

Thank you to AbbVie for their support of this Medication Review Video Module.In this medication review, Melissa Ferrari, PA, and Jennifer Hamilton, MSPAS, PA-C, provide a comprehensive overview of the...

30 Juni 17min

Populärt inom Hälsa

husmodern-med-amanda-schulman
somna-med-henrik
rss-bara-en-till-om-beroende-medberoende
rss-jossan-nina
inga-beiga-morsor
bullfika
rss-vuxna-pa-latsas
rss-viktmedicinpodden
not-fanny-anymore
sexnoveller-deluxe
angestpodden
sa-in-i-sjalen
rss-hos-psykologen
johannes-hansen-podcast
rss-ronden
sova-med-dan-horning
rss-i-skallen-pa
tyngre-traningssnack
tyngre-radio
rss-lattsamt-med-kp